Yardeni Warns Fed May Need July Rate Hike to Appease Bond Vigilantes as Incoming Chair Warsh Faces Pressure Micron Technology Breaches 1 Trillion Market Cap on AIDriven Memory Demand Surge UK Imposes Sanctions on Justin Suns Crypto Exchange for RussiaRelated Business Indian Stock Market May Open Lower as Gift Nifty Signals Decline Walmart Stock Dips on Q1 Warning Consumer Pressures and Fuel Costs Weigh on Retail Giant Hengli Chinas SilktoPetrochemicals Empire Faces the Chill of US Sanctions Lotus Technology Inc LOT Q3 2025 Earnings Loss Per Share Reported Amid Limited Analyst Coverage ZW Data Action Technologies Inc CNET Q3 2011 Earnings Sharp EPS Miss as Stock Stages Surprise Gain NNDM Q1 2026 Earnings Loss Per Share of 034 as Stock Rises Amid Strategic Progress OFS Credit Company OCCI Q1 2026 Earnings Massive EPS Miss Sends Stock Lower Similarweb Q1 2026 Earnings EPS Misses Estimates but Stock Jumps 9 on Operational Progress Cirrus Logic Shares Decline Amid Broad Tech SellOff Key Support Levels Tested BranchOut Food Inc BOF Edges Higher as Stock Holds Above Key Support Level Fortive FTV Shows Modest Decline Amid Consolidation Range Nuveen Core Equity Alpha Fund JCE Holds Steady Near Resistance as Volume Patterns Suggest Caution Republic Power Group Limited RPGL Surges Support Holds Firm at 028 Nifty Hovers as Bond Yields FII Flows and Geopolitical Risks Set the Tone for DStreet This Week Saratoga Investment Corp 8125 Notes due 2027 SAY Q1 2026 Earnings Steep EPS Miss Weighs on Sentiment Despite Modest Price Recovery Assured Guaranty AGO Slips 226 as Market Pressure Builds on Insurance Sector MBINN Q1 2026 Earnings EPS Surpasses Estimates Stock Edges Lower RLAY Q1 2026 Earnings EPS Misses Consensus PreRevenue Biotech Maintains RD Focus Bragg Gaming Group BRAG Q1 2026 Earnings NarrowerThanExpected Loss Despite Stock Dip ONL Q1 2026 Earnings Significant EPS Miss Amidst Challenging Conditions ROC Q1 2026 Earnings Surprise Profit Beats Estimates Despite Tepid Market Response MRNA Q1 2026 Earnings Loss Narrower Than Expected But Stock Slips Amid Unreported Revenue PDS Biotechnology Q1 2026 Earnings Narrowed Loss Per Share and Clinical Progress Drive Positive Market Response